DHA and EPA reverse cystic fibrosis-related FA abnormalities by suppressing FA desaturase expression and activity
Open Access
- 1 February 2012
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 53 (2), 257-265
- https://doi.org/10.1194/jlr.m018101
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fibrosis patientsJournal of Lipid Research, 2011
- Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th centuryThe American Journal of Clinical Nutrition, 2011
- Linoleic acid supplementation results in increased arachidonic acid and eicosanoid production in CF airway cells and incftr−/−transgenic miceAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Cystic fibrosisThe Lancet, 2009
- Physiological roles of fatty acyl desaturases and elongases in marine fish: Characterisation of cDNAs of fatty acyl Δ6 desaturase and elovl5 elongase of cobia (Rachycentron canadum)Aquaculture, 2009
- Influence of the cystic fibrosis transmembrane conductance regulator on expression of lipid metabolism-related genes in dendritic cellsRespiratory Research, 2009
- A mechanism accounting for the low cellular level of linoleic acid in cystic fibrosis and its reversal by DHAJournal of Lipid Research, 2008
- Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolismJournal of Lipid Research, 2008
- Docosahexaenoic acid (DHA) and hepatic gene transcriptionChemistry and Physics of Lipids, 2008
- Peroxisomal retroconversion of docosahexaenoic acid (22:6(n−3)) to eicosapentaenoic acid (20:5(n−3)) studied in isolated rat liver cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991